Preliminary programme
FRIDAY 16 May
14:00 – 14:55
Clinical trial meeting
Meeting room 12
15:00 – 15:05
Opening BMUC meeting
HIBA meeting room
Siska Van Bruwaene
Renal cell carcinoma
Chairs: Marco Gizzi & Piet Ost
15:05 – 16:05
Future imaging for RCC
Karolien Goffin
Future landscape of 1st line mccRCC: intensification or de-escalation approach?
Thomas Powles
How to deal with oligometastases?
Chad Tang
Discussion & Q&A
16:05 – 16:30
Coffee break
Exhibition area
Prostate cancer
Chairs: Wouter Everaerts & Sylvie Rottey & Nora Sundahl
16:30 – 18:00
Screening prostate cancer in 2025. What is the most optimal approach?
R.C.N. van den Bergh
Lessons from an audit of prostate cancer services in England and Wales: National Prostate Cancer Audit
Jan van der Meulen
How can a national audit help to improve the quality of prostate cancer services? A surgeon’s perspective
Paul Cathcart
Combination treatments in first-line mCRPC
Guillaume Grisay
Discussion & Q&A
18:00 – 18:30
Reception
Exhibition area
Bladder and testis cancer
Chairs: Sylvie Rottey & Piet Ost & Julien Van Damme
18:30 – 20:00
Peri-operative systemic treatment for bladder cancer
Yohann Loriot
Stage IIA-IIB seminoma treatment options
Surgery – Thomas Van den Broeck
Radiation therapy – Chad Tang
How to integrate biology and nuclear medicine in the future decision making? – Yohann Loriot
Discussion & Q&A
20:00 – 22:00
Meet-the-expert dinner
Exhibition area
SATURDAY 17 May
09:00 – 09:05
Introduction
Siska Van Bruwaene
Late breaking session on uro-oncology
Chair: Siska Van Bruwaene
09:00 – 09:45
Radiation oncology
Benedikt Engels
Medical oncology
Simon Van Wambeke
Urology
Julien Van Damme
Supportive care and quality of life
Chairs: Marco Gizzi & Julien Van Damme
09:45 – 10:45
Nutrition and immunotherapy
Sandrine Aspeslagh
Pre-habilitation in bladder cancer
Elke Rammant
Sexuality and urological malignancies
Brecht De Coen
Discussion & Q&A
10:45 – 11:15
Coffee break
Exhibition area
Poster contest session
Chair: Brieuc Sautois
11:15 – 11:30
Presentation by poster contest winner
Prostate cancer
Chairs: Brieuc Sautois & Nora Sundahl & Siska Van Bruwaene
11:30 – 13:00
Oligometastatic prostate cancer: what do we need more?
Chad Tang
Who needs a lymphadenectomy in prostate cancer?
R.C.N. van den Bergh
Can we identify lethal prostate cancer?
Bram De Laere
Discussion & Q&A
13:00 – 13:05
Closure
Siska Van Bruwaene
13:05 – 14:00
Walking lunch
Exhibition area
RIZIV/INAMI and FANC/AFCN accreditation will be be applied for. (incl. ethics and economy accreditation)